On September 2, an industrial event across Zhaoqing and Guangzhou will write a new footnote for the development of Micropeptide Group.
In the morning, the A8 factory building at No. 2 Wende Fifth Street, Zhaoqing High-tech Zone, and the opening ceremony of the micropeptide group's Zhaoqing factory will be held here. The lion dance, ribbon cutting, unveiling, and factory visit will be launched in turn. In the afternoon, the Guangzhou Baiyun International Conference Center clearing and hall, and the new product release trend forum will take over. A number of university professors and industry experts will share themes on topics such as medical research co-creation, genetic engineering drug technology, synthetic biological recombinant proteins, and cosmetics fusion. The signing ceremony and annual new product release of the micropeptide group and the university joint laboratory will also be held at the same time.
This is not a simple factory opening ceremony, but a centralized unveiling of the Micropeptide Group's "Medical Research Co-creation · Cosmetics Joint" strategy.
I. 4.0 Smart Factory: Capacity upgrading is capacity upgrading
The Zhaoqing factory is positioned as a 4.0 high-intelligence digital factory. So-called 4.0, not simply replace the equipment with automation, but from raw material warehousing, formula weighing, manufacturing, quality inspection to warehousing and logistics, the whole process is integrated into the digital management system, so that the production data of each batch of products can be recorded, traceable and analyzed.
The factory is equipped with intelligent production lines and automated warehousing systems, and the workshop reaches a cleanliness standard of 100,000, covering a variety of dosage forms such as creams, lotions, masks, and freeze-dried powders.For brand customers, this flexible production capacity means that 3,000 test orders and 300,000 explosion orders can be smoothly switched within the same system, the sampling period is shortened, and the batch stability is improved.
< img src = "/uploads/1787224282120-5bgou8.jpg" alt = "4.0 Intelligent factory intelligent production line "/>
It is understood that the new plant has also established in-depth cooperation with international top raw material giants, with a team of experts providing technical empowerment throughout the process, intervening in raw material selection and efficacy verification from the formulation design stage, and providing global customers with one-stop customization services from concept to finished product.
II. In-depth industry-university-research collaboration: five university experts argue with each other
The academic lineup of the afternoon forum was a highlight of the event.
< img src = "/uploads/1787224282651-o0dqs3.jpg "alt =" Industry-university-research-in-depth collaborative R&D lab "/>
Professor Liu Qiang, School of Traditional Chinese Medicine, Southern Medical University, will disassemble the path and methodology of clinical research into skin care products under the title of "The Underlying Logic of Medical Research Co-creation: From Clinical Validation to Precise Transformation of Efficacy Skin Care".Professor Liu is a doctoral supervisor and a visiting scholar at Yale University. He presides over projects such as the National Natural Science Foundation, and has published more than 50 SCI papers and applied for more than 70 patents.
Xiang Qi, Director of the Medical Center of Jinan University and Vice President of Cosmetics and Drug Research, will bring the sharing of "Drug Research Homology: How Genetic Engineering Drug Technology Constructs Raw Material Barriers for Cosmetic Products" to explore the application prospects of genetic engineering technology in the development of raw materials for cosmetics and medical devices.
Dr. Zhao Jun, director of the laboratory of Anhui Medical University, focuses on the research and development of many new biological products such as interferon. He will analyze the latest progress of synthetic biotechnology in the industrialization of core raw materials such as recombinant collagen, under the title of "Medical Research Co-innovation Raw Materials: Industrial Application of Synthetic Bio-Recombinant Protein Cosmetics".
Professor Yang Zhibo, Director of the Dermatology Department of the Second Affiliated Hospital of Hunan University of Chinese Medicine, will share how clinical demand drives cosmetic product innovation from the perspective of "Dermatology Medical Repair: Clinical Standards of Medical Skin Care and Cosmetic Industrialization Innovation".
In addition, Deng Min, chairman of Pinguan.com, will release the keynote speech of "The New Cycle of Cosmetics Integration - 2026 Beauty Industry Trends and Supply Chain Value Reconstruction", and Ah Gui, chairman of China Beauty.com, will also participate.
During the forum, Micropeptide Group will also hold a joint laboratory signing ceremony with universities to further deepen industry-university-research cooperation.
III. Cosmetics Federation: From Technology Reuse to System Synergy
The four words "cosmetic union" are the core labels of the Micropeptide Group that distinguish it from a single cosmetic font number or a single mechanical font number foundry.
In the makeup number plate, Guangdong Micropeptide Biotechnology Co., Ltd. has more than 10 years of OEM/ODM foundry experience, more than 800 cooperative brands, more than 100 products have been filed for listing, and more than 70 technical achievements have been accumulated. Through ISO22716 and US GMPC double certification, 3 makeup number production bases operate together, and the product line covers many categories such as skin care, facial mask, and freeze-drying powder.
In the mechanical size section, Hunan Micropeptide Biomedical Co., Ltd., as a second-class medical device manufacturer, holds a medical device production license and has passed ISO13485 medical device quality management system certification. It has the full process capability from formulation development to registration application in the fields of recombinant collagen dressings and medical skin care products.
The opening of the Zhaoqing factory will take this cosmetic synergy to a new level.The same R&D team can serve both makeup and mechanical brand customers at the same time. The same quality control system covers the production standards of the two types of products. The same core active ingredient can be transformed under different regulatory paths.For brands, this means that solutions can be found within the micropeptide system, whether you want to do the skin care of the makeup font size effect or the layout of the mechanical font size medical aesthetic repair.
IV. New Product Launch and R&D Team
At the last session of the forum, Micropeptide Group will concentrate on releasing new products of the year.Micropeptide Group brand operation Zhang Qian has 10 years of experience in beauty brand management. He has served head brands such as Oaly Beauty Skin Treasure, Shintang, and Manchester Reiton, and is responsible for the market positioning and brand strategy of new products.Ni Qiming, general manager of R&D, is a master of science at Xiamen University. He has worked in the field of dermatology research and development of L'Oréal (China) Cosmetics Group, and has in-depth research in plant genetics and dermatology innovation.R&D Manager Peng Sheng is the deputy director of the R&D committee of the China Cosmetics Industry-University-Research Collaborative R&D Platform, leading and deeply participating in the product development of various well-known brands such as Yusu and Yifuquan.
Such a team with both market sensitivity and scientific research depth is the core support for the implementation of the Micropeptide Group's "medical research co-creation" concept.
V. Industry Observation: Second Half of the Foundry
In the cosmetics foundry industry in 2026, the logic of competition is fundamentally changing.In the early days, the competition was about production capacity and price. Later, it was about formula quantity and delivery speed. Now, what really opens the gap is R&D investment, raw material autonomy, compliance system depth, and the ability to integrate industrial, academic, and research resources.
The completion of the Micropeptide Group Zhaoqing 4.0 Smart Factory is a substantive layout in this direction.When the intelligent production line meets the university laboratory, when the size of the makeup number meets the mechanical font size technology, when the OEM foundry meets the medical research and co-creation, the role of the foundry has changed from "manufacturer" to "technology partner".
On September 2, Zhaoqing Factory Opening Ceremony and New Product Release Trend Forum, we look forward to welcoming you.
